Cargando…

Design, Synthesis and Structure—Activity Relationships of Phenylalanine-Containing Peptidomimetics as Novel HIV-1 Capsid Binders Based on Ugi Four-Component Reaction

As a key structural protein, HIV capsid (CA) protein plays multiple roles in the HIV life cycle, and is considered a promising target for anti-HIV treatment. Based on the structural information of CA modulator PF-74 bound to HIV-1 CA hexamer, 18 novel phenylalanine derivatives were synthesized via t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ji, Xiangkai, Li, Jing, Sharma, Prem Prakash, Jiang, Xiangyi, Rathi, Brijesh, Gao, Zhen, Hu, Lide, Kang, Dongwei, De Clercq, Erik, Cocklin, Simon, Liu, Chuanfeng, Pannecouque, Christophe, Dick, Alexej, Liu, Xinyong, Zhan, Peng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9502897/ https://www.ncbi.nlm.nih.gov/pubmed/36144727 http://dx.doi.org/10.3390/molecules27185995

Ejemplares similares

Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators
por: Zhang, Xujie, et al.
Publicado: (2022)

Discovery and Mechanistic Investigation of Piperazinone Phenylalanine Derivatives with Terminal Indole or Benzene Ring as Novel HIV-1 Capsid Modulators
por: Xu, Shujing, et al.
Publicado: (2022)

Discovery of novel 1,4-disubstituted 1,2,3-triazole phenylalanine derivatives as HIV-1 capsid inhibitors
por: Jiang, Xiangyi, et al.
Publicado: (2019)

TEAD–YAP Interaction Inhibitors and MDM2 Binders from DNA‐Encoded Indole‐Focused Ugi Peptidomimetics
por: Kunig, Verena B. K., et al.
Publicado: (2020)

Synthesis of acylhydrazino-peptomers, a new class of peptidomimetics, by consecutive Ugi and hydrazino-Ugi reactions
por: Barreto, Angélica de Fátima S, et al.
Publicado: (2016)

Sulfur-Switch Ugi Reaction for Macrocyclic Disulfide-Bridged Peptidomimetics
por: Vishwanatha, Thimmalapura M., et al.
Publicado: (2017)

Design, Synthesis, and Evaluation of a Set of Carboxylic Acid and Phosphate Prodrugs Derived from HBV Capsid Protein Allosteric Modulator NVR 3-778
por: Ji, Xiangkai, et al.
Publicado: (2022)

Clade-Specific Alterations within the HIV-1 Capsid Protein with Implications for Nuclear Translocation
por: Dick, Alexej, et al.
Publicado: (2022)

The sustainable synthesis of peptidomimetics via chemoenzymatic tandem oxidation–Ugi reaction
por: Madej, Arleta, et al.
Publicado: (2018)

Discovery of diarylpyrimidine derivatives bearing piperazine sulfonyl as potent HIV-1 nonnucleoside reverse transcriptase inhibitors
por: Jiang, Xiangyi, et al.
Publicado: (2023)

Synthesis of imidazo[1,2-a]pyridine-containing peptidomimetics by tandem of Groebke–Blackburn–Bienaymé and Ugi reactions
por: Kolomiiets, Oleksandr V, et al.
Publicado: (2023)

Coupling Interrupted Fischer and Multicomponent Joullié‐Ugi to Chase Chemical Diversity: from Batch to Sustainable Flow Synthesis of Peptidomimetics
por: Alfano, Antonella Ilenia, et al.
Publicado: (2021)

Recent Advances in HIV-1 Gag Inhibitor Design and Development
por: Dick, Alexej, et al.
Publicado: (2020)

Bioisosteric Replacement as a Tool in Anti-HIV Drug Design
por: Dick, Alexej, et al.
Publicado: (2020)

Subtype Differences in the Interaction of HIV-1 Matrix with Calmodulin: Implications for Biological Functions
por: Dick, Alexej, et al.
Publicado: (2021)

Synthesis of diN-Substituted Glycyl-Phenylalanine Derivatives by Using Ugi Four Component Reaction and Their Potential as Acetylcholinesterase Inhibitors
por: Prent-Peñaloza, Luis, et al.
Publicado: (2019)

Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region
por: Zhang, Tao, et al.
Publicado: (2022)

Enantioselective Ugi and Ugi-azide reactions catalyzed by anionic stereogenic-at-cobalt(III) complexes
por: Sun, Bing-Bing, et al.
Publicado: (2022)

Raising the Diversity of Ugi Reactions Through Selective Alkylations and Allylations of Ugi Adducts
por: Zidan, Alaa, et al.
Publicado: (2019)

Diverse Isoquinoline Scaffolds by Ugi/Pomeranz–Fritsch and Ugi/Schlittler–Müller Reactions
por: Wang, Yuanze, et al.
Publicado: (2019)

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
por: Feng, Da, et al.
Publicado: (2022)

Structure, Function, and Interactions of the HIV-1 Capsid Protein
por: Rossi, Eric, et al.
Publicado: (2021)

Peptidomimetics II
por: Lubell, William D
Publicado: (2016)

Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-d]pyrimidine derivatives as potent HIV-1 NNRTIs
por: Kang, Dongwei, et al.
Publicado: (2020)

Binding of a Pocket Factor to Hepatitis B Virus Capsids Changes the Rotamer Conformation of Phenylalanine 97
por: Makbul, Cihan, et al.
Publicado: (2021)

Emerging drug design strategies in anti-influenza drug discovery
por: Liu, Chuanfeng, et al.
Publicado: (2023)

New RAD51 Inhibitors to Target Homologous Recombination in Human Cells
por: Shkundina, Irina S., et al.
Publicado: (2021)

Structural basis for potent and broad inhibition of HIV-1 RT by thiophene[3,2-d]pyrimidine non-nucleoside inhibitors
por: Yang, Yang, et al.
Publicado: (2018)

Unimolecular Exciplexes by Ugi Four-Component Reaction
por: Ochs, Maria, et al.
Publicado: (2019)

From Ugi Multicomponent Reaction to Linkers for Bioconjugation
por: Ramos-Tomillero, Iván, et al.
Publicado: (2020)

Keto-Enol Tautomerism in Passerini and Ugi Adducts
por: Pertejo, Pablo, et al.
Publicado: (2021)

Highly Stereoselective Ugi/Pictet–Spengler Sequence
por: Zhang, Bidong, et al.
Publicado: (2022)

Structure and Conformation of Novel BODIPY Ugi Adducts
por: Arroyo‐Córdoba, Ismael Javier, et al.
Publicado: (2022)

Peptidomimetics in cancer targeting
por: Gomari, Mohammad Mahmoudi, et al.
Publicado: (2022)

Discovery of novel sulfonamide substituted indolylarylsulfones as potent HIV-1 inhibitors with better safety profiles
por: Gao, Shenghua, et al.
Publicado: (2023)

Structure–Activity Relationships of a Novel Capsid Targeted Inhibitor of HIV-1 Replication
por: Kortagere, Sandhya, et al.
Publicado: (2014)

Novel capsid binder and PI4KIIIbeta inhibitors for EV-A71 replication inhibition
por: Tan, Yong Wah, et al.
Publicado: (2021)

Covalently Targeted Highly Conserved Tyr318 to Improve the Drug Resistance Profiles of HIV-1 NNRTIs: A Proof-of-Concept Study
por: Zhou, Zhenzhen, et al.
Publicado: (2023)

Application of heterocyclic aldehydes as components in Ugi–Smiles couplings
por: Mason, Katelynn M, et al.
Publicado: (2016)

Two-Step Macrocycle Synthesis by Classical Ugi Reaction
por: Abdelraheem, Eman M. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_et05c53dggiautsv3efnrn4ucm